BREAKING
HUYA Stock Plunges: Q4 Revenue Crashes 83.4% YoY to $248.6M, Misses EPS by 106.5% 3 minutes ago Monte Rosa (GLUE) Reports Wider Q4 Loss of $0.55/Share vs $0.34 Estimate, Revenue Misses 22 minutes ago Monte Rosa Therapeutics, Inc. (GLUE) Reports Wider Loss Q4 EPS Estimates by 63.4% 26 minutes ago Coda Octopus (CODA) Beats Q1 Estimates with $0.08 EPS, Revenue Surges 28.6% YoY to $6.7M 37 minutes ago Bicycle Therapeutics (BCYC) Q4 Revenue Soars 1194.5% YoY to $48M, Crushing Estimates by 578% 39 minutes ago Getty Images (GETY) Q4 Revenue Surges 14.1% YoY to $282.3M 1 hour ago FINV Stock: 8 Analysts Issue Buy-or-Better Ratings as FinVolution Delivers $0.25 EPS on Flat Revenue 2 hours ago Semtech (SMTC) Beats Q4 EPS Estimates by 2.0% with $0.44 Earnings, Revenue Climbs 9.3% YoY 2 hours ago Dragonfly Energy (DFLI) Posts $14.92 Loss Per Share for Q4, Revenue at $13.1M 2 hours ago Microvast (MVST) Q4 Revenue Falls 15% to $96.4M, Adjusted EPS Loss of $0.11 Misses Estimates 2 hours ago HUYA Stock Plunges: Q4 Revenue Crashes 83.4% YoY to $248.6M, Misses EPS by 106.5% 3 minutes ago Monte Rosa (GLUE) Reports Wider Q4 Loss of $0.55/Share vs $0.34 Estimate, Revenue Misses 22 minutes ago Monte Rosa Therapeutics, Inc. (GLUE) Reports Wider Loss Q4 EPS Estimates by 63.4% 26 minutes ago Coda Octopus (CODA) Beats Q1 Estimates with $0.08 EPS, Revenue Surges 28.6% YoY to $6.7M 37 minutes ago Bicycle Therapeutics (BCYC) Q4 Revenue Soars 1194.5% YoY to $48M, Crushing Estimates by 578% 39 minutes ago Getty Images (GETY) Q4 Revenue Surges 14.1% YoY to $282.3M 1 hour ago FINV Stock: 8 Analysts Issue Buy-or-Better Ratings as FinVolution Delivers $0.25 EPS on Flat Revenue 2 hours ago Semtech (SMTC) Beats Q4 EPS Estimates by 2.0% with $0.44 Earnings, Revenue Climbs 9.3% YoY 2 hours ago Dragonfly Energy (DFLI) Posts $14.92 Loss Per Share for Q4, Revenue at $13.1M 2 hours ago Microvast (MVST) Q4 Revenue Falls 15% to $96.4M, Adjusted EPS Loss of $0.11 Misses Estimates 2 hours ago
ADVERTISEMENT
Company News

CDNL Earnings Preview: What to Watch as Cardinal Infrastructure Reports Q4 Results on March 18

Cardinal Infrastructure reports Q4 2025 on March 19 with no consensus yet available; analysts have sharply raised 2026 estimates in recent weeks.

March 17, 2026 3 min read
Company News

Cardinal Infrastructure reports Q4 2025 on March 19 with no consensus yet available; analysts have sharply raised 2026 estimates in recent weeks.

Earnings Date
Mar 18
TNS
EPS Estimate
$0.29
consensus
Analyst Rating
Call: 10:30 AM ET | Webcast

Limited historical context. Cardinal’s earnings history in the database is sparse, with no prior-quarter actuals available for comparison. The company changed its name from Civil Infrastructure Group in September 2025 and appears to be relatively new to public markets, limiting the ability to assess beat-and-raise patterns or surprise consistency.

Estimate momentum turning positive. Wall Street’s outlook for Cardinal has improved sharply in recent weeks. For the current quarter (Q4 2025), the EPS consensus stands at $0.29, up from $0.22 seven days ago and $0.22 thirty days ago—a 31.8% upward revision in the past week. One analyst raised estimates in the past seven days with no downgrades, signaling growing confidence. For full-year 2025, the EPS consensus of $1.08 is up from $1.02 a week ago, with one upward revision and zero cuts. The 2026 outlook has seen even more dramatic upgrades: the $1.65 consensus is up 30.0% from $1.27 a month ago, with one upward revision in the past week.

Wall Street leans bullish. All three analysts covering Cardinal rate the stock a Buy, with no Hold or Sell ratings in the current or prior month. The unanimous bullish stance reflects optimism about the company’s growth trajectory in a fragmented civil contracting market, though the small analyst base limits the breadth of opinion.

Recent price target hikes. DA Davidson reiterated its Buy rating on February 19 and raised its price target to $35 from $30, implying 16.2% upside from the current $30.12 price. Stifel also reiterated Buy the same day, lifting its target to $31 from $28. Both firms initiated coverage in January—DA Davidson at $30 and Stifel at $28—while William Blair initiated with an Outperform rating but no price target. The recent target increases followed the prior quarter’s results, suggesting analysts see accelerating momentum.

What to Watch: Management’s 2026 revenue guidance and commentary on project backlog composition will determine whether the recent estimate upgrades have room to run. With the stock trading near $30.12 and consensus targets at $31-$35, execution on the March 18 call at 10:30 AM ET will be critical to sustaining the bullish narrative.

This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.

ADVERTISEMENT
Tags: #CDNL